SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as community optimism grows around QNX's deepening integration into next-generation software-defined vehicles with key design wins like BMW's Neue Klasse and partnerships such as Alloy Kore with Vector, leading to expectations of accelerated revenue growth and strong Q3 earnings from its expanding automotive software portfolio.

Synthetix is a decentralized perpetual futures protocol built on Ethereum Mainnet. Synthetix uses a hybrid design — off-chain order matching on a high-performance CLOB with on-chain settlement — to deliver low latency, deep liquidity, and MEV-resistant execution while keeping custody and finality on Ethereum. Traders get CEX-like performance with on-chain security and composability. The protocol’s liquidity is provided by the Synthetix Liquidity Provider (SLP) vault and backstopped by staked SNX collateral, which underwrites the issuance of the sUSD stablecoin and the solvency of the SLP vault.

Synthetix Network 

Synthetix Network is trending due to the launch of its V3 perpetuals on Ethereum Mainnet, alongside a widely discussed $1 million trading competition and a strategic shift to a deflationary token model with upcoming buybacks. The community is buzzing with both bullish excitement for this return to L1 derivatives infrastructure and caution regarding market volatility.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals (VNDA) is trending following the FDA's approval of BYSANTI (milsaperidone) for Bipolar I Disorder and Schizophrenia, with market participants eagerly anticipating a significant re-rating of its valuation. The drug's New Chemical Entity (NCE) status and patent protection through 2044, combined with the potential of its GLP-1 nausea candidate, are fueling widespread community discussion about a possible near-term buyout.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending after reporting overwhelmingly positive Phase 2 trial results for sonelokimab in axSpA, with the community celebrating its "disease-modifying" potential and best-in-class efficacy, leading to widespread speculation about a significant re-rating, potential buyout, and high anticipation for its upcoming investor day.

Berachain

Berachain (BERA) is trending amid recent network upgrades like Bectra, new Proof-of-Liquidity reward vault approvals, and a notable crypto treasury initiative with Greenlane Holdings. The community is sharply divided, with bulls highlighting its growing TVL and unique PoL model for potential gains, while bears voice concerns over recent token unlocks and selling pressure.

Insight Enterprises, Inc. engages in the provision of information technology (IT) hardware, software, and services. The firm offers supply chain optimization, connected workforce, cloud and data center transformation, and digital innovation. It operates through the following geographical segments: North America, Europe, Middle East, and Africa (EMEA), and Asia-Pacific (APAC). The company was founded by Eric J. Crown and Timothy A. Crown in 1988 and is headquartered in Chandler, AZ.

Insight Enterprises Inc.

Insight Enterprises is trending following its Q4 earnings recap, which revealed strong GAAP EPS growth and a positive outlook, complemented by strategic moves like a new AWS collaboration and the Sekuro cybersecurity acquisition. The community remains divided, discussing the company's strong positioning in digital transformation and cloud against some revenue misses, fueling active debate and technical plays including short squeeze speculation.

BlackRock Institutional Trust Company N.A. - iShares Core S&P Mid-Cap ETF

iShares Core S&P Mid-Cap ETF

The iShares Core S&P Mid-Cap ETF is trending due to community discussions around its recent stock split and overall strong performance, with upcoming forced buying from UiPath's inclusion in the S&P MidCap 400 further fueling enthusiasm for mid-cap exposure and a potential market rotation.

Sprott Funds Trust. - Sprott Copper Miners ETF

$COPP is gaining significant attention as copper prices reach record highs, primarily driven by discussions around potential import tariffs and increasing demand for AI infrastructure and global electrification. The community is actively debating the prospects of a copper supercycle amid ongoing supply challenges.

Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company was founded on June 17, 2015 and is headquartered in New York, NY.

Dianthus Therapeutics Inc

Dianthus Therapeutics is gaining attention following numerous analyst upgrades and raised price targets, driven by strong Phase 2 data for its Claseprubart program and a recently priced public offering. The community is keenly focused on the stock's long-term potential in the immunology market and upcoming clinical catalysts for its expanding pipeline.

Lithium Argentina AG is a resource and materials company that engages in the production of lithium carbonate for lithium-ion batteries and electric vehicles. Its projects include: Cauchari-Olaroz and Pastos Grandes. The company was founded by Raymond Edward Flood, Jr. on November 27, 2007 and is headquartered in Zug, Switzerland.

Lithium Argentina AG

Lithium Argentina (LAR) is trending as lithium prices surge due to tightening supply and rising demand from various sectors, positioning the in-production miner to capitalize immediately. Investors are actively discussing LAR's significant production ramp-up, expansion plans with Ganfeng, and recent analyst upgrades, viewing it as a deeply undervalued play within the re-energized lithium sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


1288clbcom

1288clbcom